← All trials
NCT04275193
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2020
- Primary completion
- Mar 1, 2022
- Completion date
- Sep 1, 2022
- First posted
- Feb 19, 2020
- Last posted
- Feb 19, 2020
- Enrollment
- 118
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Shanghai University of Traditional Chinese MedicineLead sponsor
- Shanghai UniversityStudy chair
- Jiao Tong UniversityStudy chair
- Jiao Tong UniversityCollaborator
- Shanghai University of Traditional Chinese MedicineReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.